Literature DB >> 17537994

Mosaicism due to myeloid lineage restricted loss of heterozygosity as cause of spontaneous Rh phenotype splitting.

Günther F Körmöczi1, Eva-Maria Dauber, Oskar A Haas, Tobias J Legler, Frederik B Clausen, Gerhard Fritsch, Markus Raderer, Christoph Buchta, Andreas L Petzer, Diether Schönitzer, Wolfgang R Mayr, Christoph Gassner.   

Abstract

Spontaneous Rh phenotype alteration interferes with pretransfusion and prenatal blood group examinations and may potentially indicate hematologic disease. In this study, the molecular background of this biologic phenomenon was investigated. In 9 patients (3 with hematologic disease), routine RhD typing showed a mixture of D-positive and D-negative red cells not attributable to transfusion or hematopoietic stem-cell transplantation. In all patients, congenital and acquired chimerism was excluded by microsatellite analysis. In contrast to D-positive red cells, D-negative subpopulations were also negative for C or E in patients genotyped CcDdee or ccDdEe, respectively, which suggested the presence of erythrocyte precursors with an apparent homozygous cde/cde or hemizygous cde/- genotype. Except for one patient with additional Fy(b) antigen anomaly, no other blood group systems were affected. RH genotyping of single erythropoietic burst-forming units, combined with microsatellite analysis of blood, different tissues, sorted blood cell subsets, and erythropoietic burst-forming units, indicated myeloid lineage-restricted loss of heterozygosity (LOH) of variable chromosome 1 stretches encompassing the RHD/RHCE gene loci. Fluorescent in situ hybridization studies indicated that LOH was caused by either somatic recombination or deletion. Therefore, most cases of spontaneous Rh phenotype splitting appear to be due to hematopoietic mosaicism based on LOH on chromosome 1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17537994     DOI: 10.1182/blood-2007-01-068106

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

1.  Will Genotyping Replace Serology in Future Routine Blood Grouping? - Opinion 3.

Authors:  Diether Schönitzer
Journal:  Transfus Med Hemother       Date:  2009-05-11       Impact factor: 3.747

2.  Acquired RhD mosaicism identifies fibrotic transformation of thrombopoietin receptor-mutated essential thrombocythemia.

Authors:  Celina Montemayor-Garcia; Rebecca Coward; Maher Albitar; Rupa Udani; Prachi Jain; Eleftheria Koklanaris; Minoo Battiwalla; Siobán Keel; Harvey G Klein; A John Barrett; Sawa Ito
Journal:  Transfusion       Date:  2017-06-26       Impact factor: 3.157

3.  Transfusion support for a woman with RHD*09.01.02 and the novel RHD*01W.161 allele in trans.

Authors:  K Srivastava; M U Bueno; W A Flegel
Journal:  Immunohematology       Date:  2022-04-29

Review 4.  Frameshift variations in the RHD coding sequence: Molecular mechanisms permitting protein expression.

Authors:  Willy A Flegel; Kshitij Srivastava
Journal:  Transfusion       Date:  2020-10-09       Impact factor: 3.337

5.  Somatic mosaicisms of chromosome 1 at two different stages of ontogenetic development detected by Rh blood group discrepancies.

Authors:  Eva-Maria Dauber; Wolfgang R Mayr; Hein Hustinx; Marlies Schönbacher; Holger Budde; Tobias J Legler; Margit König; Oskar A Haas; Gerhard Fritsch; Günther F Körmöczi
Journal:  Haematologica       Date:  2018-09-20       Impact factor: 9.941

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.